Top Performing Stocks To Watch For 2014

The healthcare sector has been the best-performing sector YTD with a gain of 21.3%.

(click to enlarge)

In this article, I will feature two healthcare companies that have seen intensive insider selling during the last 30 days. Intensive insider selling can be defined by the following three criteria:

The stock was sold by three or more insiders within one month.The stock was not purchased by any insiders in the month of intensive selling.At least two sellers decreased their holdings by more than 10%.

1. Illumina (ILMN) develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa.

(click to enlarge)

Top 10 Oil Service Stocks To Watch For 2015: Omega Protein Corporation(OME)

Omega Protein Corporation, a nutritional ingredient company, engages in the processing, marketing, and distribution of fish meal, oil, and soluble products. The company produces and sells various protein and oil products derived from menhaden, a herring-like species of fish found in the U.S. coastal waters of the Atlantic Ocean and Gulf of Mexico. Its fish meal products include the Special Select, a premium grade fish meal that is targeted for monogastrics, including baby pigs, pets, shrimps, and fish; SeaLac, a premium grade fish meal that is targeted for the ruminant industry; and Fair Average Quality Meal, a commodity grade fish meal that is used in protein blends for catfish, pets, and other animals. Omega Protein Corporation?s fish oil products comprise crude unrefined fish oil, refined fish oil, and food grade oils. Its oil products are used in food production, feed production, certain industrial applications, and dietary supplements. The company?s fish solubles in clude Neptune fish concentrate that is used as the attractant in commercial baits, as well as in shrimp and finfish diets; OmegaGrow, a liquid soil or foliar-applied fertilizer for plant nutrition; and OmegaGrow Plus, a liquid foliar-applied fertilizer for plant nutrition that also helps to control insect and fungus problems. The company sells its products in the United States Mexico, Europe, Canada, Asia, and South and Central America. Omega Protein Corporation was founded in 1998 and is based in Houston, Texas.

Advisors' Opinion:

• [By Garrett Cook]

  Non-cyclical consumer goods & services shares fell 0.76 percent on Tuesday. Top losers in the sector included Diamond Foods (NASDAQ: DMND), down 4.2 percent, and Omega Protein (NYSE: OME), off 3.6 percent.

Top Performing Stocks To Watch For 2014: Image Systems Nordic AB (IS)

Image Systems Nordic AB, formerly Digital Vision AB, is a Sweden-based company active in the media industry. The Company specializes in high resolution image processing, film scanning and solutions for motion analysis. The Company operates within three business areas: Media, Defense and Motion. The Company�� product portfolio includes the Nucoda software products, providing a suite of colour grading and finishing solutions used in film and television post production; the Phoenix software products, providing image restoration tools for film archives and content owners; the Golden Eye film scanners, which provide high resolution scanning, archive and restoration, and the Image Systems Motion Unit with its TEMA software platform, providing a range of motion analysis solutions, among others. As of March, 1, 2012, the Company acquired Sawco Holding AB and RemaControl Sweden AB. As of March 31, 2012, the Company�� largest shareholder was Tibia Konsult AB (19.1%). Advisors' Opinion:

• [By Geoff Gannon]

  ��The ranking exercise (is) based on growth and fundamental analysis. EXC ranks at the bottom in both analyses��op 4 results are Apple, BHP Billiton (BHP), Mosaic (MOS) and Rio Tinto (RIO). MOS was eliminated as it has one year of negative FCF.

Top Performing Stocks To Watch For 2014: ParkerVision Inc.(PRKR)

Parkervision, Inc. engages in the design, development, and sale of proprietary radio frequency (RF) technologies and products for use in semiconductor circuits for wireless communication products in the United States. The company provides its wireless technologies for processing RF waveforms in wireless applications. Its technology applies to transmit and receive functions of a radio transceiver. Its transmit portion of the technology, Direct2Power, enables the transformation of a baseband data signal to an RF carrier waveform at the desired power output level in a single unified operation. The company?s receiver portion of the technology, Direct2Data, enables the direct conversion of an RF carrier to a baseband data signal. It also provides engineering consulting and design services to its customers to assist them in developing prototypes and/or products incorporating its technologies. The company licenses its intellectual property and sells integrated circuits for incor poration into wireless devices designed by its customers. It primarily focuses on incorporating its technologies into mobile handsets, as well as to other wireless products that are related to networks serving mobile handsets, such as data cards, femtocells, and machine-to-machine and embedded applications. The company?s technology is also used in non-cellular radio applications comprising military radios. In addition, Parkervision, Inc. develops wireless radio modules for mobile handset and data card applications through a joint development and marketing agreement with LG Innotek Co., Ltd. It serves mobile handset manufacturers and their chipset suppliers in the mobile handset industry. The company was founded in 1989 and is headquartered in Jacksonville, Florida.

Advisors' Opinion:

• [By Paul Ausick]

  Stocks on the Move: Amarin Corp. plc (NASDAQ: AMRN) is down 61.1% at $2.01 after failing to gain FDA approval for its Vascepa drug. ParkerVision Inc. (NASDAQ: PRKR) is up 61.2% at $5.43 after a Florida jury ruled in the company�� favor in a patent suit against Qualcomm Inc. (NASDAQ: QCOM).

• [By Roberto Pedone]

  
  

  One under-$10 technology player that's quickly moving within range of triggering a major breakout trade is ParkerVision (PRKR), which designs, develops and markets its proprietary radio frequency technologies and products for use in semiconductor circuits for wireless communication products. This stock has been red hot so far in 2013, with shares up sharply by 105%.

  If you take a look at the chart for ParkerVision, you'll notice that this stock has been uptrending strong for the last month, with shares soaring higher from its low of $2.38 to its recent high of $4.29 a share. During that uptrend, shares of PRKR have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed share of PRKR back above both its 50-day and 200-day moving averages. Shares of PRKR have now moved within range of triggering a major breakout trade.

  Traders should now look for long-biased trades in PRKR if it manages to break out above some near-term overhead resistance at $4.29 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 2.51 million shares. If that breakout triggers soon, then PRKR will set up to re-fill some of its previous gap down zone from late October that started at $7.50 a share. Some possible upside targets if PRKR gets into that gap down zone with volume are $5 to $6 a share.

  Traders can look to buy PRKR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day moving average of $3.90 a share, or near its 50-day moving average of $3.56 a share. One can also buy PRKR off strength once it takes out $4.29 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Markman Advisors]

  Public companies leveraging their patent portfolios, (aka "patent plays"), are getting the market's attention. Companies such as Vringo (VRNG), ParkerVision (PRKR), MGT Capital (MGT), Worlds Inc. (WDDD.OB) and others have presented trading opportunities due to their volatility while retaining the chance for a big payoff to those investors who stay the course. Yet there exist viable patent plays that are still undiscovered. Some of these so called "plays," which are not getting enough attention, are actually real companies making and selling real products or services in contrast to pure patent monetization companies. Some known examples are Single Touch Interactive (SITO.OB) and Blue Calypso (BCYP.OB). This article is focused on another one of these patent plays, On Track Innovations Ltd. (OTIV).

Top Performing Stocks To Watch For 2014: Haemonetics Corp (HAE)

Haemonetics Corporation, incorporated on August 29, 1985, is a healthcare company engaged in providing blood management solutions to its customers. The Company�� portfolio of integrated devices, information management and consulting services offers blood management solutions for each facet of the blood supply chain, helping improve clinical outcomes and reduce costs for blood and plasma collectors, hospitals, and patients around the world.The Company serves three markets: manufacturers of plasma derived pharmaceuticals, blood collectors and hospitals. Plasma includes plasma collection devices and consumables. Blood Center includes blood collection and processing devices and consumables. Hospital includes surgical blood salvage and blood demand diagnostic devices and consumables. Software Solutions includes information technology platforms and consulting services provided to all three markets. On April 30, 2013, the Company acquired of certain assets of Hemerus LLC.

The Company helps its customers create and maintain a safe and efficient blood supply chain. Specifically, it develops and markets a wide range of systems used with plasma and blood donors that collect and process blood into its components using both manual and automated methods. It also develops and markets a variety of systems to hospitals that automate the cleaning and reinfusion of a surgical patient's blood during surgery, automate the tracking and distribution of blood in the hospital, and enhance blood diagnostics. The Company sells information technology platforms to promote efficient and compliant operations for all of its customer groups. The Company provides consulting services to reduce costs and improve operating efficiencies in blood management. . Its products and services help prevent a transfusion to a patient who does not need one and provide the right blood product, at the right time, in the right dose to the patient who does.

Plasma

Human plasma is collected and processed by bio-ph! armaceutical companies into therapeutic and diagnostic products that aid in the treatment of immune diseases and coagulation disorders. While plasma is also used to aid patients with extreme blood loss, such as trauma victims, this portion of its business solely focuses on plasma's pharmaceutical uses. Automated plasma collection technology allows for the safe and efficient collection of plasma. The Company manufactures and market plasma collection devices and respective disposables, but do not make plasma-derived pharmaceuticals.

The Company�� portfolio of products and services is designed to support multiple facets of plasma collector operations. The Company with its PCS brand automated plasma collection technology, more plasma can be collected during any one donation event because the other blood components are returned to the donor through the sterile disposable sets used for the plasma donation procedure. The Company offers one stop shopping to its plasma collection customers, enabling them to source from them the full range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and consumables, plasma collection containers, and intravenous solutions. It also offers a robust portfolio of integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain. Its products automate the donor interview and qualification process; streamline the workflow process in the plasma center; provide the controls necessary to evaluate donor suitability; determine the ability to release units collected; and manage unit distribution.

Blood Center

The Company offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products.The Company markets the MCS (Multicomponent Collection System) brand apheresis equipment which is designed to collect specific blood components integrated from the donor. Utilizing t! he MCS au! tomated platelet collection protocols, blood centers collect one or more therapeutic doses of platelets during a single donation by a volunteer blood donor. The MCS two-unit protocol or double red cell collection device helps blood collectors optimize the collection of red cells by automating the blood separation function, eliminating the need for laboratory processing, and enabling the collection of two units of red cells from a single donor thus maximizing the amount of red cells collected per eligible donor and helping to mitigate red cell shortages in countries where this problem exists. Blood collectors can also use the MCS system to collect one unit of red cells and a jumbo (double) unit of plasma, or one unit of red cells and one unit of platelets from a single donor. The MCS plasma protocol providing the possibility to collect 600-800ml of plasma for transfusion to patients or for pharmaceutical industry use completes the comprehensive portfolio of different blood component collection options on this device.

The Company offers a portfolio of products for manual whole blood collection and processing. Haemonetics' portfolio of disposable whole blood collection and component storage sets offer flexibility in collecting a unit of whole blood and the subsequent production and storage of the red blood cell, platelet, and/or plasma products, including options for in-line or dockable filters for leukoreduction of any blood component. In addition Acrodose product line provides a closed system for the pooling, storage, and bacteria testing of leukoreduced whole blood derived platelet concentrates, an Acrodose Platelet, that is transfusion ready for the hospital. Use of Acrodose platelets lowers hospital handling costs by eliminating the need for pooling and bacteria testing at the hospital.

The Company with ACP(Automated Cell Processor) brand offers a small bench-top solution to automate the washing and freezing of red cell components in the lab. The automated red cell was! hing proc! edure removes plasma proteins within the red cell units to provide a safer product for transfusion to frequently transfused patients, neonates, or patients with a history of transfusion reactions. The automated glycerolization and deglycerolization steps are required to prepare red cells for frozen storage. Freezing the red cell units can expand the shelf life of these products up to 10 years. Customers utilize this technology to implement strategic red cell inventories for catastrophe cases, storage of rare blood types, or enhanced inventory management.

Hospital

The Company offers a range of blood management solutions that significantly improve a hospital's systems for acquiring blood, storing it in the hospital, and dispensing it efficiently and correctly. Its products and integrated solution platforms help hospitals optimize performance of blood acquisition, storage, and distribution.The Company�� TEG Thrombelastograph Hemostasis Analyzer system is a blood diagnostic instrument that measures a patient's hemostasis or the ability to form and maintain blood clots.

The Cell Saver system is a surgical blood salvage system targeted to procedures that involve rapid, high-volume blood loss, such as cardiovascular surgeries. It has become the standard of care for high blood-loss surgeries. During the year ended December 31,2012, the Company launched the Cell Saver Elite system, which is autotransfusion option to minimize allogeneic blood use for surgeries with medium to high blood loss. The OrthoPAT surgical blood salvage system is targeted to procedures, such as orthopedic, that involve slower, lower volume blood loss that often occurs well after surgery. The cardioPAT system is a surgical blood salvage system targeted to open heart surgeries when there is less blood loss during surgery, but where the blood loss continues post-surgery. These systems are designed to remain with the patient following surgery, to recover blood and produce a washed red cell produ! ct for au! totransfusion. Their Quick-Connect feature permits customers to utilize the blood processing set selectively, depending on the patient's need.

The Company�� IMPACT Online Web-based software platform, which monitors and measures improvements in a hospital�� blood management practices, provides hospitals with a baseline view of their blood management metrics and helps monitor transfusion rates. Business consulting solutions are offered to support process and blood management efforts. It also provides blood management assessment tools to hospitals that enables its customers to monitor their progress in order to continually improve their blood management performance.

Software Solutions

The Companby has a suite of integrated software solutions for improving efficiencies and helping ensure donor and patient safety. This includes solutions for blood drive planning, donor recruitment and retention, blood collection, component manufacturing and distribution, transfusion management, and remote blood allocation. For its plasma customers, it also provides information technology platforms for managing donors and information associated with the collection of plasma products within fractionation facilities.

The Company�� software solutions , including information technology platforms and consulting services can be combined with its devices and sold through its plasma, blood center, and hospital sales forces. The Company�� software products help hospitals track and safely deliver stored blood products. SafeTrace Tx is its software solution that helps manage blood product inventory, perform patient cross-matching, and manage transfusions. In addition, its BloodTrack suite of solutions manages tracking and control of blood products from the hospital blood center through to transfusion to the patient. Smart refrigerators located in or near operating suites, emergency rooms, and other parts of the hospital dispense blood units with secure control and autom! ated trac! eability for efficient documentation. With its offerings, hospitals are better able to manage processes across the blood supply chain and identify increased opportunities to reduce costs and enhance processes. Its software solutions, such as its SafeTrace and El Dorado Donor donation and blood unit management systems, span blood center operations and automate and track operations from the recruitment of the blood donor to the disposition of the blood product. Its Hemasphere software solution provides support for more efficient blood drive planning, and Donor Doc and e-Donor software help to improve recruitment and retention.

The Company competes with Fenwal, Inc., Terumo BCT ,Caridian BCT, Rotem, MAK Systems, Mediware, MacoPharma , Medtronic, Fresenius, Sunquest Information Systems and Sorin Biomedica.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Haemonetics (NYSE: HAE  ) , whose recent revenue and earnings are plotted below.

• [By Lisa Levin]

  Haemonetics (NYSE: HAE) shares fell 8.57% to reach a new 52-week low of $30.40 after the company Q4 adjusted earnings of $0.46 per share on revenue of $241.10 million. The company's board also announced a $100 million share buyback program.

• [By Holly LaFon]

  Haemonetics (HAE) is the market leader in blood management products for collection centers and hospitals. The company's equipment and related consumables allow collection centers to separate blood into the components of plasma, red cells and white cells. Hospital-based products include blood diagnostics, devices to salvage patient blood during surgery and software to manage blood supply. Earnings temporarily declined due to two product quality issues that management of Haemonetics has stated have been remedied. In our opinion, earnings growth may be expected to accelerate in the next few years as Haemonetics rolls out its automated whole blood collection solution to collection centers. Relative to the existing manual process, the company's automated solution speeds up the collection process and reduces discard rates. Cost and efficiency gains become more important to collection centers as hospitals better manage their blood supply. We believe the company is a compelling value at 12x our $3.50 estimate of earnings power.

Top Performing Stocks To Watch For 2014: MAKO Surgical Corp.(MAKO)

MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific osteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment. The company?s MAKOplasty partial knee arthroplasty solution enables resurfacing of one or two specific diseased compartments of the joint, preserving more soft tissue and healthy bone of the knee; and MAKOplasty Total Hip Arthroplasty, a surgical solution that enables orthopedic surgeons to pe rform total hip arthroplasty. In addition, it offers tactile guidance system, which allows orthopedic surgeons to treat degenerative knee osteoarthritis from early-stage unicompartmental degeneration through mid-stage multicompartmental degeneration with a modular knee implant system; and RESTORIS family of implants for use in single and bicompartmental knee resurfacing procedures. The company markets its products through direct sales force, as well as through independent orthopedic product agents and distributors. MAKO Surgical Corp. was founded in 2004 and is headquartered in Fort Lauderdale, Florida.

Advisors' Opinion:

• [By Sean Williams]

  What's more, what goes for Intuitive Surgical likely goes double for MAKO Surgical (NASDAQ: MAKO  ) , a robotic surgical device maker for orthopedic knee and hip procedures. Because MAKO is currently unprofitable the boom and bust it could experience because of its unique niche versus the effects of Obamacare could really be a huge catalyst. Take clues from MAKO's management as another indicator of where Intuitive may head next and keep your eyes fixated on Intuitive's July 18 report.

• [By Rich Smith]

  Fort Lauderdale, Fla.-based MAKO Surgical (NASDAQ: MAKO  ) shares were surging today on news that the company has settled its patent infringement dispute with Stanmore Implants Worldwide.

• [By Steve Symington]

  But, while iRobot is focusing on hospital bedside care, other robotics companies like�Intuitive Surgical�and MAKO Surgical (NASDAQ: MAKO  ) are commanding a place in the operating room.

Top Performing Stocks To Watch For 2014: Ampco-Pittsburgh Corporation(AP)

Ampco-Pittsburgh Corporation and its subsidiaries manufacture and sell custom-engineered equipment in the United States and internationally. It operates in two segments, Forged and Cast Rolls, and Air and Liquid Processing. The Forged and Cast Rolls segment produces forged hardened steel rolls used in cold rolling for the producers of steel, aluminum, and other metals; and cast iron and steel rolls for hot and cold strip mills, medium/heavy section mills, and plate mills. The Air and Liquid Processing segment manufactures finned tube and plate finned heat exchange coils for the commercial and industrial construction, as well as for process and utility industries; custom air handling systems used in commercial, institutional, and industrial buildings; and a line of centrifugal pumps for the refrigeration, power generation, and marine defense industries. The company was founded in 1929 and is based in Pittsburgh, Pennsylvania.

Advisors' Opinion:

• [By Mae Anderson] ATLANTA (AP) ��Finding a knockoff version of the fur you want under the Christmas tree would ordinarily be a disappointment.

  Not this year.

• [By Andrea Kay]

  In this picture provided by the Vatican newspaper L'Osservatore Romano, Pope Francis engages with his audience, speaking with a child during his three-hour visit Dec. 21, 2013, to Bambino Gesu' pediatric hospital in Rome.(Photo: AP)